Detalles de la búsqueda
1.
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
Circulation
; 145(21): 1581-1591, 2022 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510542
2.
Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
Circulation
; 140(2): 103-112, 2019 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31117810
3.
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c <â¯7% are associated with lower major cardiovascular events.
Am Heart J
; 225: 97-107, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32480059
4.
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circulation
; 136(25): 2440-2450, 2017 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28972004
5.
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Circulation
; 134(12): 861-71, 2016 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27576775
6.
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med
; 370(18): 1702-11, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24678955
7.
Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.
Am Heart J
; 188: 156-166, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577671
8.
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
Circulation
; 131(12): 1047-53, 2015 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25681464
9.
Vorapaxar in the secondary prevention of atherothrombotic events.
N Engl J Med
; 366(15): 1404-13, 2012 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22443427
10.
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
N Engl J Med
; 367(14): 1297-309, 2012 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22920930
11.
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
Circulation
; 128(8): 823-33, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23852610
12.
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome.
Am Heart J
; 165(6): 918-925.e2, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23708162
13.
Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).
Circulation
; 123(23): 2681-9, 2011 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21606391
14.
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
Am J Med
; 135(7): 915-918, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296402
15.
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
J Am Coll Cardiol
; 77(19): 2366-2377, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985681
16.
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation
; 118(16): 1626-36, 2008 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-18757948
17.
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
J Am Heart Assoc
; 6(1)2017 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077384
18.
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation
; 112(22): 3391-9, 2005 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-16301343
19.
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients.
Heart
; 102(15): 1221-9, 2016 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27030601
20.
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.
JAMA Cardiol
; 1(4): 425-32, 2016 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27438319